Literature DB >> 31471572

Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies.

Richard J Lin1, Theresa A Elko2, Sean M Devlin3, Armin Shahrokni4,5, Ann A Jakubowski2,5, Parastoo B Dahi2,5, Miguel-Angel Perales2,5, Roni Tamari2,5, Brian C Shaffer2,5, Craig S Sauter2,5, Esperanza B Papadopoulos2,5, Boglarka Gyurkocza2,5, Beatriz Korc-Grodzicki4,5, Juliet N Barker2,5, Molly A Maloy2, Sergio A Giralt6,7.   

Abstract

Older patients are at increased risk for complications and death following allogeneic hematopoietic cell transplantation (allo-HCT). Traditional transplant-specific prognostic indices such as hematopoietic cell transplant comorbidity index (HCT-CI) may not capture all underlying geriatric vulnerabilities, and in-depth evaluation by a geriatrician prior to transplant may not always be available. We hypothesize that routine pretransplant interdisciplinary clinical assessment may uncover prognostically important geriatric deficits. Using an institutional database of 457 adults aged 60 years and older who underwent first allo-HCT for hematological malignancies from 2010 to 2017, we examined the prognostic impact of pretransplant deficits in geriatric domains of function, mobility, mood, medication, nutrition, and relevant biochemical markers. We found that impairment in instrumental activities of daily living (IADL) was associated with reduced survival through increased nonrelapse mortality (NRM, HR = 1.82; 95% CI, 1.04-3.19). The combination of IADL impairment with either HCT-CI/age index or disease risk index readily stratified NRM and overall survival, respectively. In addition, we found that even mild renal dysfunction adversely impacted survival in older transplant patients. Our findings establish important geriatric vulnerabilities in older patients prior to allo-HCT and may provide an entry point for prospective, interventional trials to improve their outcomes.

Entities:  

Mesh:

Year:  2019        PMID: 31471572      PMCID: PMC6940509          DOI: 10.1038/s41409-019-0654-6

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  11 in total

1.  Allogeneic hematopoietic cell transplantation for older patients.

Authors:  Richard J Lin; Andrew S Artz
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

2.  The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patients.

Authors:  Richard J Lin; Laure Michaud; Stephanie M Lobaugh; Reiko Nakajima; Audrey Mauguen; Theresa A Elko; Josel D Ruiz; Molly A Maloy; Craig S Sauter; Parastoo B Dahi; Miguel-Angel Perales; Gunjan L Shah; Nerea Castillo Flores; Míriam Sanchez-Escamilla; Ana Alarcón Tomas; Lucrecia Yáñez San Segundo; Christina Cho; Ioannis Politikos; Soo Jung Kim; Beatriz Korc-Grodzicki; Sean M Devlin; Michael Scordo; Heiko Schöder; Sergio A Giralt; Paul A Hamlin
Journal:  Leuk Lymphoma       Date:  2020-03-31

3.  Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes.

Authors:  Rebecca L Olin; Caitrin Fretham; Marcelo C Pasquini; Mukta Arora; Vijaya R Bhatt; Benjamin Derman; Sergio A Giralt; Li-Wen Huang; Thuy Koll; Sang Mee Lee; Richard J Lin; Linda Pang; Uday R Popat; Daniel J Weisdorf; Andrew Artz
Journal:  Blood Adv       Date:  2020-06-23

4.  Discharge Disposition Following Hematopoietic Cell Transplantation: Predicting the Need for Rehabilitation and Association with Survival.

Authors:  Sarah A Wall; Qiuhong Zhao; Sumithira Vasu; Ashley Rosko
Journal:  Transplant Cell Ther       Date:  2020-12-17

Review 5.  Pitfalls and Successes in Trials in Older Transplant Patients with Hematologic Malignancies.

Authors:  Aaron T Zhao; Anthony D Sung
Journal:  Curr Oncol Rep       Date:  2022-01-21       Impact factor: 5.075

Review 6.  Geriatric assessment in older patients with a hematologic malignancy: a systematic review.

Authors:  Ellen R M Scheepers; Ariel M Vondeling; Noortje Thielen; René van der Griend; Reinhard Stauder; Marije E Hamaker
Journal:  Haematologica       Date:  2020-05-07       Impact factor: 9.941

Review 7.  Multidisciplinary Approach to Older Adults with Hematologic Malignancies-a Paradigm Shift.

Authors:  Sarah A Wall; Erin Stevens; Jennifer Vaughn; Naresh Bumma; Ashley E Rosko; Uma Borate
Journal:  Curr Hematol Malig Rep       Date:  2022-01-13       Impact factor: 4.213

8.  Impact of allogeneic stem cell transplantation comorbidity indexes after haplotransplant using post-transplant cyclophosphamide.

Authors:  Maxime Jullien; Corentin Orvain; Ana Berceanu; Marie-Anne Couturier; Thierry Guillaume; Pierre Peterlin; Alice Garnier; Amandine Le Bourgeois; Marion Klemencie; Aline Schmidt; Mathilde Hunault; Etienne Daguindau; Xavier Roussel; Pascal Delepine; Gaelle Guillerm; Aurelien Giltat; Sylvie François; Sylvain Thepot; Steven Le Gouill; Marie-C Béné; Patrice Chevallier
Journal:  Cancer Med       Date:  2021-09-21       Impact factor: 4.452

9.  The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT.

Authors:  Roni Shouval; Joshua A Fein; Christina Cho; Scott T Avecilla; Josel Ruiz; Ana Alarcon Tomas; Miriam Sanchez-Escamilla; Nerea Castillo Flores; Lucrecia Yáñez; Juliet N Barker; Parastoo Dahi; Sergio A Giralt; Alexander I Geyer; Boglarka Gyurkocza; Ann A Jakubowski; Richard J Lin; Richard J O'Reilly; Esperanza B Papadopoulos; Ioannis Politikos; Doris M Ponce; Craig S Sauter; Michael Scordo; Brian Shaffer; Gunjan L Shah; James P Sullivan; Roni Tamari; Marcel R M van den Brink; James W Young; Arnon Nagler; Sean Devlin; Avichai Shimoni; Miguel-Angel Perales
Journal:  Blood Adv       Date:  2022-03-08

Review 10.  Rehabilitation after Allogeneic Haematopoietic Stem Cell Transplantation: A Special Challenge.

Authors:  Hartmut Bertz
Journal:  Cancers (Basel)       Date:  2021-12-08       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.